Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Status:
Recruiting
Trial end date:
2026-09-23
Target enrollment:
Participant gender:
Summary
This is a prospective, phase II, stratified single arm investigation for favorable prognosis
in p16+ oropharynx cancer patients with either node negative or malignant neck adenopathy
with lymphoscintigraphy mapping confined to the ipsilateral neck.